Search the Newsreel

Bull of the Day: Monolithic Power Systems (MPWR)

Monolithic Power Systems MPWR designs, develops, and markets high-performance power solutions. The company focuses on the market for high-performance analog and mixed-signal integrated circuits (ICs). Its products are widely used in industrial applications, telecommunications infrastructure, cloud computing, and automotive and consumer applications. The stock …

Duality Biotherapeutics Sets Board Meeting to Approve 2026 Interim Results

Erste Asset Management GmbH Has $17.39 Million Stock Position in Monolithic Power Systems, Inc. $MPWR

Monolithic Power Systems, Inc. $MPWR Shares Purchased by Florida Trust Wealth Management Co

BF Utilities delays Q1FY27 consolidated results

Cambridge Investment Research Advisors Inc. Raises Stock Holdings in Monolithic Power Systems, Inc. $MPWR

What's Going On With Infrastructure Dividend Split Corp. Stock Friday?

BF Utilities Q1FY26 net loss widens to ₹503M on lower other income

Ryman Hospitality Properties (RHP) Buys Grande Lakes Orlando, Is The Stock Fairly Valued?

Ryman Hospitality Properties (RHP) has acquired the Grande Lakes Orlando Resort for US$1.38 billion, accompanied by new equity and debt financing. Despite a recent share price rally and analyst targets suggesting fair valuation, Simply Wall St's analysis indicates the stock is about 7% undervalued …

Prairie Lithium Wins ASX Quotation for 200 Million New Shares

AMPG|Amplitech Group Inc|Price:5.960|Chg%:-0.450

ABN Amro Investment Solutions Trims Position in Essential Utilities Inc. $WTRG

ABN Amro Investment Solutions has reduced its stake in Essential Utilities Inc. (NYSE:WTRG) by 24.8% during the second quarter, selling 25,050 shares but still retaining 75,980 shares valued at $2.91 million. This comes as Essential Utilities reported slightly strong earnings, beating EPS expectations and …

Canadian Utilities (TSE:CU) Stock Crosses Above Two Hundred Day Moving Average - Here's Why

Belite Bio Inc (BLTE) (Q2 2026) Earnings Call Highlights: FDA Priority Review and Strong Cash ...

This article first appeared on GuruFocus. Release Date: August 13, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Belite Bio Inc (NASDAQ:BLTE) received FDA acceptance of its New Drug Application (NDA) for Tinlarabant …

Jindalee Lithium Limited (ASX:JLL)banks $10.9m and sets NASDAQ path as McDermitt heads back to drill

Little Green Pharma (ASX:LGP)Hits Record Revenue as Europe Overtakes the Home Market

DMCC Speciality Chemicals posts sharp Q1 growth but warns profits may normalise

Country Club Hospitality & Holidays consolidated net profit rises 61.54% in the June 2026 quarter

AmpliTech Group, Inc. Q2 2026: Revenue $8.07M, EPS $(0.12) — 10-Q Summary

AmpliTech Group, Inc. reported its Q2 2026 financial results, showing a decrease in revenue to $8.07M from $11.03M in the prior year, alongside a wider net loss of $3.09M and a diluted loss per share of $0.12. The company noted improved gross profit due …

Why Does Little Green Pharma (ASX:LGP) Shape Quality?

Sigma Lithium (SGML) Production Beat Puts Fair Value Back In Focus

Sigma Lithium (SGML) exceeded its Q2 2026 production guidance, delivering 35,000 tonnes of high-grade lithium concentrate, which has brought its fair value back into focus for investors. Analysts view the stock as undervalued, with a fair value of around $17.17 compared to its current …

Alithya Group Inc. 2027 Q1 - Results - Earnings Call Presentation (TSX:ALYA:CA) 2026-08-13

Key Points Interested in Alithya Group Inc.? Here are five stocks we like better. First-quarter results weakened significantly: Revenue fell 15.4% year over year to CAD 105.1 million, while adjusted EBITDA declined to CAD 5.4 million and the company posted a CAD 2.4 million …

Monolithic Power Systems director Herbert Chang sells $71,000 in stock

Monolithic Power Systems director Herbert Chang sold 50 shares of company stock for $71,000 on August 11, 2026, reducing his direct beneficial ownership to 565 shares. Despite the stock appearing overvalued according to InvestingPro, analysts project a 34% upside potential, with price targets ranging …

AmpliTech outlines 2026 priorities while declining to reaffirm $50M full-year revenue guidance amid deployment timing shifts

Earnings Call Insights: AmpliTech Group, Inc. (AMPG) Q2 2026 MANAGEMENT VIEW * CEO Fawad Maqbool described Q2 as “an important period in AmpliTech's continued transformation and growth,” adding that results reflected “a deliberate increase in investment as we position AmpliTech to pursue and support …

Delta Lithium Director Receives New Performance Rights Under Incentive Plan

Delta Lithium Director Boosts Performance Rights Through Incentive Plan

Delta Lithium awards performance-based rights to director Steve Kovac

Jindalee Lithium (ASX:JLL): Why Does McDermitt Matter Now?

Should Apple Hospitality REIT’s Raised Guidance and Renovation Push Require Action From APLE Investors?

In August 2026, Apple Hospitality REIT reported second-quarter revenue of US$402.55 million and net income of US$67.08 million, while also raising full-year net income guidance and outlining US$85 million to US$95 million of 2026 capital improvements across roughly 18 hotels. The company's decision to …

RCI Hospitality Holdings (RICK) Q3 2026 Earnings Call Transcript

RCI Hospitality Holdings (RICK) reported increased revenue and net income for Q3 2026, with Bombshells segment revenue up 25.4% due to new locations and a strategic shift to a beverage-focused model. The company also saw stable performance in its Nightclubs division, growing 1%. Management …

DMCC Speciality Chemicals Q1FY27 PAT up 163% to ₹20.40 Cr on price surge

Qualitas Real Estate Income Fund Announces July 2026 Distribution at 8% Annualised Yield

Creative Realities, Inc. (CREX) Stock Price, News, Quote & History

ALYA: Revenue and margins declined, but strong pipeline and strategic review signal future growth potential

Monolithic Power Systems (NASDAQ:MPWR) Director Kuo Wei Herbert Chang Sells 50 Shares of Stock

Belite Bio outlines February 12, 2027 PDUFA date for Tinlarebant in Stargardt disease following FDA priority review acceptance

Earnings Call Insights: Belite Bio (BLTE) Q2 2026 MANAGEMENT VIEW * Dr. Tom Lin (Chairman of the Board of Directors & CEO) framed the quarter around U.S. regulatory timing, saying, "the FDA has accepted our new drug application for Tinlarebant with priority review and …